Applications of genetically modified animals

Journal de la Société de biologie
L M Houdebine

Abstract

The first transgenic animals, mice, were obtained in 1980. The techniques of gene transfer had to be adapted to obtain transgenic animals with an acceptable yield in about fifteen species. When the yield is low (low rate of random integration and targeted integration via homologous recombination), genetic modifications must be achieved in intermediate cells able to participate to the development of chimeric transgenic animals (ES cells, EG cells, iPS obtained by the dedifferentiation of somatic cells) or in somatic cells used as nuclear donor to generate transgenic clones. Various tools make possible a marked increase of homologous recombination efficiency (meganucleases and ZFN), or a gene inactivation at the genome level (direct or conditional knock out) or at the mRNA level (interfering RNAs). Vectors allow a more reliable transgene expression. Genetically modified animals are used mainly to obtain information on biological functions and human diseases. Transgenic animals produce recombinant pharmaceutical proteins in milk and soon in egg white. Pig organs adapted to be tolerated by patients might be tested in humans in five years. The projects based on the use of transgenesis to improve animal production are presently few. ...Continue Reading

References

Mar 6, 1998·Molecular and Cellular Biology·M Cohen-TannoudjiF Jaisser
Aug 2, 2001·Nature Biotechnology·S P GolovanC W Forsberg
May 1, 2002·Nature Biotechnology·Patrick H C van BerkelPeter H Nibbering
Jan 28, 2003·Nature Biotechnology·Brigid BrophyGötz Laible
Apr 7, 2004·Proceedings of the National Academy of Sciences of the United States of America·Kazuhiro SaekiAkira Iritani
Nov 10, 2004·Proceedings of the National Academy of Sciences of the United States of America·Etsuro OnoToshimitsu Uede
Apr 5, 2005·Nature Biotechnology·Robert J WallHarold W Hawk
Aug 6, 2005·Nature Biotechnology·Matthew H Porteus, Dana Carroll
Mar 28, 2006·Nature Biotechnology·Liangxue LaiYifan Dai
Jun 9, 2006·Nature·Marie-Cecile van de LavoirRobert J Etches
Aug 22, 2006·Current Gene Therapy·Alexander Pfeifer
Jan 2, 2007·Nature Biotechnology·Jürgen A RichtYoshimi Kuroiwa
Mar 21, 2007·Transgenic Research·Pedro N MoreiraLluís Montoliu
May 8, 2007·Nature Biotechnology·Jing X Kang, Alexander Leaf
Jan 10, 2008·Nature Biotechnology·Martin F Pera, Kouichi Hasegawa
Feb 5, 2008·Comparative Immunology, Microbiology and Infectious Diseases·G Laible
Feb 5, 2008·Comparative Immunology, Microbiology and Infectious Diseases·Louis-Marie Houdebine
Apr 11, 2008·Proceedings of the National Academy of Sciences of the United States of America·John H Wilson
Jun 10, 2008·Nature Biotechnology·Ian G Woods, Alexander F Schier
Aug 12, 2008·Comparative Immunology, Microbiology and Infectious Diseases·Stefan MoisyadiRyuzo Yanagimachi

❮ Previous
Next ❯

Citations

Aug 9, 2018·Frontiers in Plant Science·Nadia R ChalfounAtilio P Castagnaro

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.